BioMarin Announces Governance Enhancements and Value Creatio

BioMarin Announces Governance Enhancements and Value Creation Initiatives

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today...

Related Keywords

Indiana , United States , Indiana University , Northeastern University , Massachusetts , California , Boston , American , Alexander Hardy , Iovance Biotherapeutics , Traci Mccarty , Eli Lilly , Athena Countouriotis , Barbara Bodem , Richarda Meier , Los Angeles , Marc Steinberg , Mark Enyedy , Marni Kottle , Daiichi Sankyo , Pfizer , Nasdaq , Prnewswire Biomarin Pharmaceutical Inc , University Of California , Biotechnology Innovation Organization , Bristol Myers Squibb , Pediatric Hematology Oncology Program , Fred Hutchinson Cancer Research Center , Jones Day , Enovis Corporation , Harvard Law School , Dentsply Sirona Inc , Company Establishes Strategic , Financial Analyst For Irwin Management Company , Biomarin Pharmaceutical Inc , Jp Morgan Securities , American Cancer Society Of Eastern New England , Head Of Corporate Development , Exchange Commission , Goldman Sachs , Invacare Corporation , Genzyme Corporation , Tufts University School Of Medicine , Committee Of The Board , Syneos Health , Mallinckrodt Pharmaceuticals , Board Approves Appointment , Three New Independent , Establishes Strategic , Operating Review Committee , Marin Enters , Information Sharing Agreements , Marin Pharmaceutical , Operating Review , Biomarin Board , Elliott Investment Management , Cooperation Agreement , Senior Portfolio Manager Marc Steinberg , Nature Conservancy , Interim Chief Financial Officer , Senior Vice President , Chief Financial Officer , Chief Financial , Vice President , Financial Analyst , Tirwin Management , Turning Point Therapeutics , Chief Executive Officer , Chief Medical Officer , Adverum Biotechnologies , Ambit Biosciences , Tufts University School , Executive Vice President , Corporate Development , Proteostasis Therapeutics , American Cancer Society , Eastern New England , Biotechnology Innovation , Logicbio Therapeutics , Akebia Therapeutics , Fate Therapeutics , Biomarin Pharmaceutical , Quarterly Report ,

© 2025 Vimarsana